1. Switzerland Stocks

  2. •

    Health technology

  3. •

    Medical specialties
IVF HARTMANN Holding AG

IVF HARTMANN Holding AG

123.00
CHF
-3.00
(-2.38%)
309.58MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
52.23
55.36
55.08
56.1
55.4
55.55
57.49
72.08
60.1
62.81
61.63
66.17
67.34
- -
Basic EPS, GAAP
6.39
6.57
6.7
6.85
6.67
5.86
5.07
7.43
2.59
4.68
6.31
8.46
7.62
- -
Free Cash Flow per Basic Share
6.26
5.15
6.75
6.55
5.46
3.35
1.57
8.04
-3.74
6.26
13.08
7.42
7.28
- -
Dividend per Share
1.9
2.05
2.2
2.3
2.4
2.5
2.5
2.5
3.5
1.9
2.5
8.2
6.2
- -
Book Value per Share
29.29
33.81
38.32
42.87
47.14
50.5
53.07
58
57.09
59.86
63.07
63.33
65.26
65.75
Tangible Book Value per Share
29.1
33.68
38.19
42.74
46.78
49.69
51.82
56.4
55.25
58.33
61.95
62.64
64.83
65.39
Basic Weighted Avg Shares
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Sales/Revenue/Turnover
125
133
132
135
133
133
138
173
144
151
148
159
162
- -
Operating Margin (%)
14.55
14.08
14.33
14.65
12.37
10.66
10.22
12.1
4.8
8.82
11.2
14.44
12.91
- -
Depreciation Expense
3
3
3
3
3
4
4
4
6
6
5
5
5
- -
Net Income, GAAP
15
16
16
16
16
14
12
18
6
11
15
20
18
- -
Effective Tax Rate (%)
16.49
16.31
15.44
16.27
16.16
15.86
13.91
14.52
13.85
14.64
15.41
15.78
14.52
- -
Profit Margin (%)
12.23
11.87
12.16
12.21
12.04
10.55
8.82
10.31
4.31
7.45
10.24
12.79
11.32
- -
Working Capital
47
56
65
77
85
87
86
91
89
99
114
118
122
124
LT Debt
- -
- -
- -
- -
- -
- -
1
1
- -
1
1
1
1
- -
Total Equity
70
81
92
103
113
121
127
139
137
144
151
152
155
157
Return on Invested Capital (%)
23.57
20.4
18.02
16.63
14.57
11.79
9.83
13.19
4.72
8.14
9.47
12.53
11.59
- -
Return on Capital (%)
23.65
20.84
18.59
16.99
14.87
12.1
9.91
13.48
4.75
8.15
10.2
13.29
11.82
- -
Return on Common Equity (%)
23.65
20.84
18.59
16.88
14.82
12.01
9.79
13.37
4.5
8
10.27
13.38
11.9
- -

Capital Structure

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
1
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
336
341
310

Working Capital

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
143
159
160
Cash, Cash Equivalents & STI
94
112
108
Accounts Receivable, Net
22
23
26
Inventories
24
22
24
Total Current Liabilities
31
37
36
Payables & Accruals
- -
- -
- -
ST Debt
- -
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.46%
2.26%
2.25%
Free Cash Flow
-4.86%
-70.01%
-1.87%
Net Income, GAAP
9.51%
14.94%
-9.89%
Sales/Revenue/Turnover
2.48%
-0.95%
1.81%
Total Cash Common Dividend
- -
45.9%
-24.39%

Semi-annual Revenue

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
159
2025
- -
- -
162
2026
- -
- -
- -

Semi-annual Earnings Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
8.46
2025
- -
- -
7.62
2026
- -
- -
- -

Semi-annual Dividends Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
8.2
2025
- -
- -
6.2
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Martin Walther
Full Time Employees
316
Sector
Health technology
Industry
Medical specialties
Address
Victor von Bruns-Strasse 28 Neuhausen SH Switzerland 8212
IPO Date
Jul 16, 2012
Website
ivf.hartmann.info
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
IVF Hartmann Holding AG IVF Hartmann Holding AG is a Switzerland-based holding company that produces and distributes medical consumer goods, focusing on medical supplies, pharmaceutical products, and hygiene items for hospitals, pharmacies, doctors, surgery centers, care centers, drugstores, wholesalers, and corporate medical centers. The company offers a broad range of core products including wound care dressings and bandages such as elastic bandages and rheumatism plasters; incontinence management and feminine hygiene solutions; infection management items like disinfection and cleaning equipment, surgical disposables, and hand sanitizers; first aid kits and diagnostics equipment; body care and personal hygiene products including cotton wool and baby care items; as well as accident prevention gear, X-ray protection clothing, household tools, packaging, and textile products; it also provides bandage manufacturing machinery and consulting services on product usage. Founded in 1874 and headquartered in Neuhausen am Rheinfall, Switzerland, IVF Hartmann Holding AG operates primarily in Switzerland with international reach and functions as a subsidiary of Paul Hartmann Finance B.V., employing around 270 to 340 staff across segments like wound care, incontinence management, infection management, and other group activities. In recent developments, the company reported strong financial growth for fiscal year 2024 with revenue rising 7.23% to CHF 159.03 million, net income up 34.02% to CHF 20.3 million, and EPS increasing to CHF 8.46, driven by new product launches, market share gains, and a stable balance sheet under its ongoing transformation program; it commissioned Apleona Schweiz AG in 2023 for facility management at its headquarters, reflecting operational enhancements, while maintaining a focus on organic expansion without major acquisitions or partnerships in 2024-2025.